About
Biosystems Immunolab develops in-vitro diagnostic tests based on patented protein epitope profiling technology for early detection and differential diagnosis of lung cancer using a simple blood test called Pulmolisa.
Explore Biosystems Immunolab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.